[Skip to Content]
[Skip to Content Landing]

Factors Affecting Interpretation of Hormone Concentrations for Diagnosis of Endocrine Disease

Learning Objectives
1. Explain the variability of hormone measurements and the importance of accurate, comparable, and reliable measurements
2. Utilize hormone measurements to diagnose patients
3. Apply common methodologies for standardization
1 Credit

Welcome to Accurate Hormone Testing, a new 4-part course from Endocrine Society and the Partnership for the Accurate Testing of Hormones (PATH) exploring the endocrinologist's main tool, hormone assays. This course, developed with support from the National Association of Chronic Disease Directors, seeks to educate fellows and endocrinologists on the importance of, and methods to ensure, accurate hormone testing.

This is module 4 of a 4-module course that focuses on different aspects of accurately testing and reading hormone assays.

Sign in to take quiz and track your certificates

Endocrine Society logo

Endocrine Society is a global community of physicians and scientists energized by the promise of unraveling the mysteries of hormone disorders to care for patients and cure disease. Learn more

To help improve the quality of its educational content and meet applicable education accreditation requirements, the content provider will receive record of your participation and responses to this activity.

Video Information

© 2023 Copyright Endocrine Society. All rights reserved.

Disclosure Statement:


As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's guideline task force.


The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships:

John Fuqua, MD: Data Monitoring Committee Member - Merck; Treasurer of Board of Directors - Pediatric Endocrine Society.

The following peer-reviewers reported relevant financial relationships:

Robert Fitzgerald, PhD: Advisory Board Member - Roche Diagnostics.

Alvin M. Matsumoto, MD: Research Support - AbbVie, GlaxoSmithKline; UpToDate - Editor; Board of Directors - United States Anti-Doping Agency; Scientific Advisory Board - Partnership for Clean Competition.

The following peer-reviewers reported no relevant financial relationships: Hubert Vesper, PhD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.


This educational activity is supported by the Endocrine Society and the National Association of Chronic Disease Directors Partnership to Improve Laboratory Measurements of Chronic Disease Biomarkers project.

The Partnership to Improve Laboratory Measurements of Chronic Disease Biomarkers project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $100,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Participation Statement: Upon completion of this activity, learners will receive a Participation Certificate.


Name Your Search

Save Search

Lookup An Activity


My Saved Searches

You currently have no searches saved.


My Saved Courses

You currently have no courses saved.